dm+d
29896003
Articles
Corticosteroids monitoring
15 July 2021
Managing risks of betamethasone soluble tablets used as mouthwash
9 July 2021
Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm Medicine Compliance Aid Stability
generic
RPH Pharmaceuticals AB
RPH Pharmaceuticals AB
generic
Tablets soluble 0.5mg
R2 · Red 2 Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablet unsuitable for MCA
1 November 2022
Betnesol
Recipharm Limited (UK)
Recipharm Limited (UK)
Betnesol
Tablets soluble 500microgram
R2 · Red 2 Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets so unsuitable for MCA.
25 October 2022
Lactation Safety Information
Oral / Parenteral
Oral / Parenteral
Prednisolone (oral), Hydrocortisone (parenteral)
No published evidence of safety
Used in infants >1 month
Doses up to 8mg daily unlikely to cause adverse effects in the infant
24 September 2020
Local injection
Local injection
24 September 2020
For ophthalmic use
For ophthalmic use
There are no additional risks when used in combination ophthalmic preparations containing neomycin
24 September 2020
For use in the ear
For use in the ear
There are no additional risks when used in combination aural preparations containing neomycin
24 September 2020
For intranasal use
For intranasal use
24 September 2020
Soluble tablets for orophayngeal use
Soluble tablets for orophayngeal use
24 September 2020
All esters for topical use
All esters for topical use
High potency
There are no additional risks when used in combination topical preparations containing antimicrobials or salicylic acid
24 September 2020